Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1970 Jan;6(1):87-99.

On the mechanism of immunological tolerance in cyclophosphamide-treated mice

On the mechanism of immunological tolerance in cyclophosphamide-treated mice

A Many et al. Clin Exp Immunol. 1970 Jan.

Abstract

The mechanism of immunological tolerance of sheep red blood cells (SRBC) in mice treated with a single dose of cyclophosphamide was studied. Specific tolerance lasted for as long as nine months in some animals, and its maintenance required the repeated administration of SRBC. Anti-SRBC antibody-forming cells were significantly reduced in the tolerant mice, and X-irradiated recipients of their spleens were specifically tolerant of SRBC. The smallest number of SRBC required for the induction of tolerance was 107; this was the smallest number of SRBC that could elicit antibody synthesis within 5 days in normal mice. Since the effects of cyclophosphamide on antibody-forming cells last only 5 days, it was concluded that the mechanism of tolerance induction involved destruction of antigen-stimulated cells. In support of this is the finding that mice treated with small doses of cyclophosphamide were rendered tolerant only when SRBC were given before the drug. Drug-induced immunological tolerance thus appears to differ significantly from both pneumococcal polysaccharide paralysis and classical, acquired tolerance. A central loss of immunocompetence does not occur in the former, while the latter requires for its induction the administration of antigen in a dose or form that does not stimulate antibody synthesis.

PubMed Disclaimer

References

    1. J Immunol. 1963 May;90:703-10 - PubMed
    1. J Exp Med. 1967 May 1;125(5):833-45 - PubMed
    1. Nature. 1959 Jun 13;183(4676):1682-3 - PubMed
    1. Nature. 1965 Nov 27;208(5013):859-61 - PubMed
    1. J Immunol. 1962 Mar;88:320-9 - PubMed

Substances

LinkOut - more resources